Title:
フタロシアニン化合物ならびにこれを用いるリポソーム製剤および癌／腫瘍治療剤
Document Type and Number:
Japanese Patent JP7222071
Kind Code:
B2
Abstract:
The present invention provides a phthalocyanin compound that has a maximum absorption wavelength of 780 nm or more and is soluble with respect to phospholipids. The phthalocyanin compound of the present invention has a structure in which one to eight lipid-derived groups are introduced into a phthalocyanin skeleton, and a central metal is an oxide or halide of vanadium, an oxide or halide of indium, or an oxide of tin.
Inventors:
Masashi Kiyoshi
Masato Imase
Masato Imase
Application Number:
JP2021507347A
Publication Date:
February 14, 2023
Filing Date:
March 16, 2020
Export Citation:
Assignee:
Nippon Shokubai Co., Ltd.
International Classes:
C09B47/067; A61K9/127; A61K31/409; A61K31/685; A61K41/00; A61K47/54; A61P35/00
Domestic Patent References:
| JP4039361A | ||||
| JP2001106689A | ||||
| JP2013108060A | ||||
| JP2014500273A | ||||
| JP2018522825A |
Foreign References:
| WO2013051732A1 |
Attorney, Agent or Firm:
IBC Ichibancho Patent Attorney Corporation
Previous Patent: Interventional device positioning using ultrasound signals
Next Patent: VIDEO IMAGE DISPLAY DEVICE
Next Patent: VIDEO IMAGE DISPLAY DEVICE